FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
FutureFemHealth Pro
Partners and contributors
Archive
About
The cost of censorship: digital restrictions are hitting women’s health businesses
New CensHERship research finds 43% of respondents have lost revenue as a result of digital censorship and suppression, while the proportion…
 • Anna O'Sullivan
What if vaginal microbiome testing becomes routine?
Evvy’s $40m Series B sent me looking at where the vaginal microbiome market goes next - and what becomes valuable as testing moves closer to healthcare.
 • Anna O'Sullivan
💌 Evvy’s $40m Series B, Eli Lilly’s women’s health push + Wisp expands
+ lots more in the weekly briefing on the global women's health market
 • Anna O'Sullivan
New white paper makes the business case for teaching every doctor about menopause
With just 6.8% of residents feeling prepared to manage menopause, the new white paper argues the knowledge gap needs to be tackled before doctors…
 • Anna O'Sullivan
Aitiologic raises €6.4m seed to advance preeclampsia risk test
Vienna-based precision medicine company is developing technology to identify preeclampsia risk from the same first-trimester blood sample already used…
 • Anna O'Sullivan
Evvy raises $40m Series B to take its vaginal microbiome platform further into women’s health
CEO Priyanka Jain tells FutureFemHealth why Evvy is expanding into new areas of women’s health
 • Anna O'Sullivan
Wisp expands into broader women’s health platform after reaching 2m patients
New CEO appointed for next phase of growth
 • Anna O'Sullivan
What if the next women’s health diagnostic doesn’t require another test?
A new use for mammography is the latest example of a strategy gaining commercial traction across women’s health: getting more health information from…
 • Anna O'Sullivan
Viv raises $2m to expand period care brand and launch new tampon technology
Patented tampon design developed to prevent cotton fibres being left behind in body
 • Anna O'Sullivan
Issue 162: Mainstream bank launches women’s health fund | €15m pregnancy diagnostics raise | inhaled IVF drugs
+ lots more in the weekly briefing on the global women's health market
 • Anna O'Sullivan
Femtech France launches Europe-wide women’s health innovation forum
First Forum taking place in Paris this November
 • Anna O'Sullivan
💌 Issue 161: $35m for preeclampsia | new heart attack guidance | Flo’s IPO signal | birth injury investment
+ lots more in the weekly briefing on the global women's health market
 • Anna O'Sullivan
© 2026 FutureFemHealth Ltd · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture